Desmond Padhi is the founder of Latigo Biotherapeutics. Latigo Biotherapeutics has raised $135M in total funding. Latest round: Series A.
Desmond Padhi is an Operating Partner at Westlake Village BioPartners and was the interim CEO of Latigo Biotherapeutics. He helped launch Latigo Biotherapeutics to develop non-opioid pain medicines, incubating the company through Westlake Village BioPartners.
Full founder directory · Investor directory · Company funding database · Fundraising library